Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib with Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer
NCT00513695Phase 2Completed
- Sponsor
- University of Washington
- Start
- Jun 2007
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in breast cancer, sponsored by University of Washington. Started Jun 2007; status: completed.
02
Drugs
sunitinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00513695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00513695.